Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 30, 2024 03:00 ET | Source: Anaveon

Anaveon announces presentation of new data on development compounds ANV700 and ANV600 at the Society for Immunotherapy of Cancer 2024 Annual Meeting

Anaveon announces presentation of new data on development compounds ANV700 and ANV600 at the Society for Immunotherapy of Cancer 2024 Annual Meeting
July 30, 2024 02:00 ET | Source: Anaveon

Anaveon appoints Dieter Weinand as Chair of its Board of Directors

BASEL, Switzerland, July 30, 2024 (GLOBE NEWSWIRE) -- Anaveon, a clinical stage, immuno-oncology company, today announced the appointment of Dieter Weinand, former Chair and CEO of Bayer...
May 29, 2024 02:00 ET | Source: Anaveon

Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study

Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study